Cite
HARVARD Citation
Kabarriti, R. et al. (n.d.). PO-1045: Addition of SBRT following TACE is associated with a survival benefit in Hepatocellular Carcinoma. Radiotherapy and oncology. pp. S556-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kabarriti, R. et al. (n.d.). PO-1045: Addition of SBRT following TACE is associated with a survival benefit in Hepatocellular Carcinoma. Radiotherapy and oncology. pp. S556-. [Online].